Remove trial restrictions Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Mallinckrodt
Moodys
Colorcon
McKinsey

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR VELTASSA


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Veltassa

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00868439 ↗ Evaluation of Patiromer in Heart Failure Patients Completed Medpace, Inc. Phase 2 2009-04-01 The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.
NCT00868439 ↗ Evaluation of Patiromer in Heart Failure Patients Completed Relypsa, Inc. Phase 2 2009-04-01 The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.
NCT01130597 ↗ Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease Completed Relypsa, Inc. Phase 2 2010-05-01 The purpose of this study was to evaluate the feasibility of individualized titration of patiromer according to serum potassium. This study also assessed the safety and tolerability of patiromer and the effects of patiromer on serum potassium in heart failure (HF) participants with chronic kidney disease (CKD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Veltassa

Condition Name

Condition Name for Veltassa
Intervention Trials
Hyperkalemia 9
Heart Failure 2
Chronic Kidney Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Veltassa
Intervention Trials
Hyperkalemia 11
Renal Insufficiency, Chronic 6
Kidney Diseases 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Veltassa

Trials by Country

Trials by Country for Veltassa
Location Trials
United States 83
Brazil 12
Spain 9
Germany 7
Mexico 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Veltassa
Location Trials
California 6
New York 6
Florida 6
Texas 6
Michigan 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Veltassa

Clinical Trial Phase

Clinical Trial Phase for Veltassa
Clinical Trial Phase Trials
Phase 4 5
Phase 3 2
Phase 2 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Veltassa
Clinical Trial Phase Trials
Completed 7
Active, not recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Veltassa

Sponsor Name

Sponsor Name for Veltassa
Sponsor Trials
Relypsa, Inc. 10
Vifor Pharma, Inc. 2
New York University School of Medicine 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Veltassa
Sponsor Trials
Industry 14
Other 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKesson
AstraZeneca
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.